Product NDC: | 40042-025 |
Proprietary Name: | Etomidate |
Non Proprietary Name: | Etomidate |
Active Ingredient(s): | 2 mg/mL & nbsp; Etomidate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 40042-025 |
Labeler Name: | PharmaForce, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078867 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100608 |
Package NDC: | 40042-025-10 |
Package Description: | 10 VIAL, GLASS in 1 CARTON (40042-025-10) > 10 mL in 1 VIAL, GLASS |
NDC Code | 40042-025-10 |
Proprietary Name | Etomidate |
Package Description | 10 VIAL, GLASS in 1 CARTON (40042-025-10) > 10 mL in 1 VIAL, GLASS |
Product NDC | 40042-025 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Etomidate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100608 |
Marketing Category Name | ANDA |
Labeler Name | PharmaForce, Inc. |
Substance Name | ETOMIDATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |